VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $27,673,000 | +122.2% | 1,190,261 | +52.2% | 0.00% | +200.0% |
| Q1 2018 | $12,453,000 | -66.8% | 782,232 | -56.7% | 0.00% | -75.0% |
| Q4 2017 | $37,513,000 | +960.9% | 1,805,270 | +631.6% | 0.00% | – |
| Q3 2017 | $3,536,000 | +19.7% | 246,770 | +44.6% | 0.00% | – |
| Q2 2017 | $2,953,000 | +376.3% | 170,670 | +203.8% | 0.00% | – |
| Q1 2017 | $620,000 | -98.0% | 56,170 | -97.4% | 0.00% | -100.0% |
| Q4 2016 | $31,223,000 | -82.9% | 2,150,369 | -71.1% | 0.00% | -83.3% |
| Q3 2016 | $182,549,000 | -41.7% | 7,435,829 | -52.2% | 0.02% | -44.2% |
| Q2 2016 | $313,087,000 | +118.6% | 15,545,539 | +185.4% | 0.04% | +115.0% |
| Q1 2016 | $143,231,000 | -84.7% | 5,446,046 | -40.8% | 0.02% | -84.1% |
| Q4 2015 | $934,652,000 | -59.3% | 9,200,743 | -28.5% | 0.13% | -61.5% |
| Q3 2015 | $2,295,704,000 | -15.2% | 12,861,850 | +5.3% | 0.33% | -5.8% |
| Q2 2015 | $2,708,592,000 | +16.8% | 12,209,441 | +4.1% | 0.35% | +17.6% |
| Q1 2015 | $2,318,359,000 | +35.0% | 11,732,842 | -2.2% | 0.30% | +32.3% |
| Q4 2014 | $1,717,498,000 | +21.2% | 11,996,844 | +10.9% | 0.22% | +16.1% |
| Q3 2014 | $1,417,546,000 | -21.0% | 10,817,449 | -23.8% | 0.19% | -20.3% |
| Q2 2014 | $1,794,555,000 | -40.4% | 14,191,933 | -38.0% | 0.24% | -42.3% |
| Q1 2014 | $3,011,350,000 | -1.8% | 22,888,433 | -12.4% | 0.42% | -3.5% |
| Q4 2013 | $3,065,102,000 | -3.0% | 26,126,197 | -13.8% | 0.43% | -10.5% |
| Q3 2013 | $3,160,499,000 | +17.1% | 30,310,968 | -3.2% | 0.48% | +9.5% |
| Q2 2013 | $2,698,878,000 | – | 31,303,568 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |